Anesthetic Management for Wingspan Stent

REFERENCES

1. 1.↵
   1. Chimowitz MI,
   2. Lynn MJ,
   3. Howlett-Smith H,
   4. et al.

   Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 352(13):1305–1316, pmid:15800226, 2005 Mar 31.

   OpenUrlPubMed
2. 2.↵
   1. Derdeyn CP,
   2. Chimowitz MI

   (2007 Aug) Angioplasty and stenting for atherosclerotic intracranial stenosis: rationale for a randomized clinical trial. Neuroimaging Clin N Am 17(3):355–363, viii-ix, pmid:17826637.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Henkes H,
   2. Miloslavski E,
   3. Lowens S,
   4. Reinartz J,
   5. Liebig T,
   6. Kühne D

   (2005 Mar) Treatment of intracranial atherosclerotic stenoses with balloon dilatation and self-expanding stent deployment (WingSpan). Neuroradiology 47(3):222–228, pmid:15912418, Epub 2005 Mar 15.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Fiorella D,
   2. Levy EI,
   3. Turk AS,
   4. et al.

   (2007 Mar) US multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke 38(3):881–887, pmid:17290030, Epub 2007 Feb 8.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Yang J,
   2. Chai YF,
   3. Gong CY,
   4. et al.

   Further proof that the spinal cord, and not the brain, mediates the immobility produced by inhaled anesthetics. Anesthesiology 110(3):591–595, pmid:19212265, 2009 Mar.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   1. Kapinya KJ,
   2. Löwl D,
   3. Fütterer C,
   4. et al.

   Tolerance against ischemic neuronal injury can be induced by volatile anesthetics and is inducible NO synthase dependent. Stroke 33(7):1889–1898, pmid:12105371, 2002 Jul.

   OpenUrlAbstract/FREE Full Text
7. 7.
   1. Tanaka K,
   2. Ludwig LM,
   3. Krolikowski JG,
   4. et al.

   Isoflurane produces delayed preconditioning against myocardial ischemia and reperfusion injury: role of cyclooxygenase-2. Anesthesiology 100(3):525–531, pmid:15108964, 2004 Mar.

   OpenUrlCrossRefPubMedWeb of Science
8. 8.
   1. Preckel B,
   2. Schlack W,
   3. Comfère T,
   4. Obal D,
   5. Barthel H,
   6. Thämer V

   Effects of enflurane, isoflurane, sevoflurane and desflurane on reperfusion injury after regional myocardial ischaemia in the rabbit heart in vivo. Br J Anaesth 81(6):905–912, pmid:10211018, 1998 Dec.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Lange M,
   2. Redel A,
   3. Lotz C,
   4. et al.

   Desflurane-induced postconditioning is mediated by beta-adrenergic signaling: role of beta 1- and beta 2-adrenergic receptors, protein kinase A, and calcium/calmodulin-dependent protein kinase II. Anesthesiology 110(3):516–528, pmid:19225392, 2009 Mar.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Fiorella D,
    2. Woo HH

    (2007 Aug) Emerging endovascular therapies for symptomatic intracranial atherosclerotic disease. Stroke 38(8):2391–2396, pmid:17585085, Epub 2007 Jun 21.

    OpenUrlFREE Full Text
11. 11.↵
    1. Kelly ME,
    2. Turner RD,
    3. Moskowitz SI,
    4. et al.

    (2009 Jan) Revascularization of symptomatic subacute cerebrovascular occlusions with a self-expanding intracranial stent system. Neurosurgery 64(1):72–78, pmid:19050658, discussion 78.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Tobias JD

    Nicardipine: applications in anesthesia practice. J Clin Anesth 7(6):525–533, pmid:8534474, 1995 Sep.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Engelhard K,
    2. Werner C,
    3. Kaspar S,
    4. et al.

    Effect of the alpha2-agonist dexmedetomidine on cerebral neurotransmitter concentrations during cerebral ischemia in rats. Anesthesiology 96(2):450–457, pmid:11818781, 2002 Feb.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.↵
    1. Zornow MH,
    2. Maze M,
    3. Dyck JB,
    4. Shafer SL

    Dexmedetomidine decreases cerebral blood flow velocity in humans. J Cereb Blood Flow Metab 13(2):350–353, pmid:8094720, 1993 Mar.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Karlsson BR,
    2. Forsman M,
    3. Roald OK,
    4. Heier MS,
    5. Steen PA

    Effect of dexmedetomidine, a selective and potent alpha 2-agonist, on cerebral blood flow and oxygen consumption during halothane anesthesia in dogs. Anesth Analg 71(2):125–129, pmid:1973880, 1990 Aug.

    OpenUrlPubMedWeb of Science
16. 16.↵
    1. Drummond JC,
    2. Dao AV,
    3. Roth DM,
    4. et al.

    Effect of dexmedetomidine on cerebral blood flow velocity, cerebral metabolic rate, and carbon dioxide response in normal humans. Anesthesiology 108(2):225–232, pmid:18212567, 2008 Feb.

    OpenUrlCrossRefPubMedWeb of Science
17. 17.↵
    1. Bekker A,
    2. Gold M,
    3. Ahmed R,
    4. et al.

    Dexmedetomidine does not increase the incidence of intracarotid shunting in patients undergoing awake carotid endarterectomy. Anesth Analg 103(4):955–958, pmid:17000811, 2006 Oct.

    OpenUrlCrossRefPubMedWeb of Science